878101P

C17 Lyso PAF

Avanti Research^™ - A Croda Brand 878101P, powder

• 别名: 1-O-heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine
• 经验公式（希尔记法）: C₂₅H₅₄NO₆P
• CAS号: 111858-52-7
• 分子量: 495.67
• MDL號碼: MFCD22416942
• 分類程式碼代碼: 12352211
• NACRES: NA.25

属性

• 形狀: powder
• 包裝: pkg of 1 × 10 mg (878101P-10mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 878101P
• 脂質類型: bioactive lipids; phosphoglycerides
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• SMILES 字串: O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COCCCCCCCCCCCCCCCCC
• InChI: 1S/C25H54NO6P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-30-23-25(27)24-32-33(28,29)31-22-20-26(2,3)4/h25,27H,5-24H2,1-4H3/t25-/m1/s1
• InChI 密鑰: HQRBTQCLRRUGMR-RUZDIDTESA-N

说明

一般說明

C17 Lyso PAF, also known as 1-O-heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine, is a precursor and metabolite of 1-O-heptadecyl-2-acetyl-sn-glycero-3-phosphocholine (C17:0 PAF). Lyso-platelet activating factor (PAF) is synthesized from PAF acetylhydrolases by the degradation of PAF. It is also synthesized from 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine (1-alkyl-phosphatidylcholine; PC) by the enzyme phospholipase A2 via the remodeling pathway.

包裝

5 mL Amber Glass Screw Cap Vial (878101P-10mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全信息

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3